These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 16961440
1. The effects of prescription drug copayments on statin adherence. Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S. Am J Manag Care; 2006 Sep; 12(9):509-17. PubMed ID: 16961440 [Abstract] [Full Text] [Related]
2. Impact of statin copayments on adherence and medical care utilization and expenditures. Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA. Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486 [Abstract] [Full Text] [Related]
3. Lowering copayments: impact of simvastatin patent expiration on patient adherence. Sedjo RL, Cox ER. Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498 [Abstract] [Full Text] [Related]
4. Impact of decreasing copayments on medication adherence within a disease management environment. Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM. Health Aff (Millwood); 2008 Dec; 27(1):103-12. PubMed ID: 18180484 [Abstract] [Full Text] [Related]
5. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study. Ye X, Gross CR, Schommer J, Cline R, St Peter WL. Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593 [Abstract] [Full Text] [Related]
6. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Cole JA, Norman H, Weatherby LB, Walker AM. Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491 [Abstract] [Full Text] [Related]
7. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ. Circulation; 2007 Apr 24; 115(16):2128-35. PubMed ID: 17420348 [Abstract] [Full Text] [Related]
8. Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients. Gibson TB, Jing Y, Kim E, Bagalman E, Wang S, Whitehead R, Tran QV, Doshi JA. Manag Care; 2010 Aug 24; 19(8):40-7. PubMed ID: 20822071 [Abstract] [Full Text] [Related]
9. The impact of reducing cardiovascular medication copayments on health spending and resource utilization. Choudhry NK, Fischer MA, Avorn JL, Lee JL, Schneeweiss S, Solomon DH, Berman C, Jan S, Lii J, Mahoney JJ, Shrank WH. J Am Coll Cardiol; 2012 Oct 30; 60(18):1817-24. PubMed ID: 23040581 [Abstract] [Full Text] [Related]
10. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care. Taira DA, Wong KS, Frech-Tamas F, Chung RS. Am J Manag Care; 2006 Nov 30; 12(11):678-83. PubMed ID: 17090224 [Abstract] [Full Text] [Related]
11. Effect of tiered prescription copayments on the use of preferred brand medications. Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS. Med Care; 2003 Mar 30; 41(3):398-406. PubMed ID: 12618643 [Abstract] [Full Text] [Related]
12. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Maciejewski ML, Bryson CL, Perkins M, Blough DK, Cunningham FE, Fortney JC, Krein SL, Stroupe KT, Sharp ND, Liu CF. Am J Manag Care; 2010 Jan 01; 16(1):e20-34. PubMed ID: 20059288 [Abstract] [Full Text] [Related]
13. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Cheong C, Barner JC, Lawson KA, Johnsrud MT. Clin Ther; 2008 Oct 01; 30(10):1893-907. PubMed ID: 19014846 [Abstract] [Full Text] [Related]
14. The effect of switching on compliance and persistence: the case of statin treatment. Thiebaud P, Patel BV, Nichol MB, Berenbeim DM. Am J Manag Care; 2005 Nov 01; 11(11):670-4. PubMed ID: 16268750 [Abstract] [Full Text] [Related]
15. Effect of copayments on drug use in the presence of annual payment limits. Kephart G, Skedgel C, Sketris I, Grootendorst P, Hoar J. Am J Manag Care; 2007 Jun 01; 13(6 Pt 2):328-34. PubMed ID: 17567233 [Abstract] [Full Text] [Related]
16. Effect of increased copayments on pharmacy use in the Department of Veterans Affairs. Stroupe KT, Smith BM, Lee TA, Tarlov E, Durazo-Arvizu R, Huo Z, Barnett T, Cao L, Burk M, Cunningham F, Hynes DM, Weiss KB. Med Care; 2007 Nov 01; 45(11):1090-7. PubMed ID: 18049350 [Abstract] [Full Text] [Related]
17. Effect of statin adherence on cerebrovascular disease in primary prevention. Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L. Am J Med; 2009 Jul 01; 122(7):647-55. PubMed ID: 19559167 [Abstract] [Full Text] [Related]
18. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP. Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658 [Abstract] [Full Text] [Related]
19. Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy. Yang W, Kahler KH, Fellers T, Orloff J, Chang J, Bensimon AG, Wu EQ, Fan CP, Yu AP. J Med Econ; 2011 Sep 01; 14(3):267-78. PubMed ID: 21446895 [Abstract] [Full Text] [Related]
20. Associations between prescription copayment levels and β-blocker medication adherence in commercially insured heart failure patients 50 years and older. Patterson ME, Blalock SJ, Smith AJ, Murray MD. Clin Ther; 2011 May 01; 33(5):608-16. PubMed ID: 21665045 [Abstract] [Full Text] [Related] Page: [Next] [New Search]